Citation Impact
Citing Papers
Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation
2009
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center
2002
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion1
2003
Liver and kidney preservation by perfusion
2002
A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors1
2004
Delayed graft function in kidney transplantation
2004 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Selecting the Donor Liver: Risk Factors for Poor Function After Orthotopic Liver Transplantation
1994
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Waitlist Mortality Decreases with Increased Use of Extended Criteria Donor Liver Grafts at Adult Liver Transplant Centers
2007
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Nonalcoholic Steatohepatitis in Donors for Living Donor Liver Transplantation
2007 Nobel
DONOR NUTRITIONAL STATUS-A DETERMINANT OF LIVER PRESERVATION INJURY1
1996
Implication of advanced donor age on the outcome of liver transplantation
2000
THE IMPACT OF DONOR AGE ON LIVER TRANSPLANTATION: INFLUENCE OF DONOR AGE ON EARLY LIVER FUNCTION AND ON SUBSEQUENT PATIENT AND GRAFT SURVIVAL
2001
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function
2005
Serum cholestasis markers as predictors of early outcome after liver transplantation
2004
Angiotensin–Converting Enzyme Inhibition by Enalapril: A Novel Approach to Reduce Ischemia/Reperfusion Damage After Experimental Liver Transplantation
1997
Classification of Surgical Complications
2004 Standout
The utility of marginal donors in liver transplantation
2003
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients
2001
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Role of anti-tumor necrosis factor-?? in ischemia/reperfusion injury in isolated rat liver in a blood-free environment
2002
Liver transplantation
2000
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
HEPATITIS C INFECTION IN PATIENTS UNDERGOING LIVER RETRANSPLANTATION1,2
1998
Non-heart beating organ donation: overview and future perspectives
2007
Impact of human leukocyte antigen matching in liver transplantation
2003
Influence of donor age on graft survival after liver transplantation-united network for organ sharing registry
1995
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis
2004
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
The global NAFLD epidemic
2013 Standout
Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation
2010
Critical care issues in patients after liver transplantation
2011
USE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVAL
1996
Measurement of liver tissue oxygenation after orthotopic liver transplantation using a multiparameter sensor
2002
Nonalcoholic fatty liver disease
2010
Cholangiocarcinoma
2007 Standout
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma
1997
PREOPERATIVE FACTORS ASSOCIATED WITH OUTCOME AND THEIR IMPACT ON RESOURCE USE IN 1148 CONSECUTIVE PRIMARY LIVER TRANSPLANTS
2001
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
NAFLD: A multisystem disease
2015 Standout
Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation
2003
The therapeutic potential of carbon monoxide
2010 Standout
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
2012
Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation
1994
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Liver transplantation from maastricht category 2 non–heart-beating donors: a source to increase the donor pool?
2004
Extended-Donor Criteria Liver Allografts
2006
Predictors of Survival After In Vivo Split Liver Transplantation
2000
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model
2017
Primary Biliary Cirrhosis
2011 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION
1998
Part 8: Post–Cardiac Arrest Care
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization
1999
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of ROBERT M. HOFFMANN being referenced
RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS
1993
Liver transplantation from controlled non-heart–beating donors
2000
The Use of UW Solution in Clinical Transplantation A 4-year Experience
1992
Infant pediatric liver transplantation results equal those for older pediatric patients
1998
SUCCESSFUL EXTRARENAL TRANSPLANTATION FROM NON-HEART-BEATING DONORS
1995
Should abdominal cluster transplantation be abandoned?
1993